Helvetica Chimica Acta – Vol. 92 (2009)
289
dried (MgSO4). CC (5 ꢃ 60 cm SiO2, CH2Cl2) gave, in this order, 5 (55 mg, 0.8%), 3 (3.42 g, 55%), and 4
(1.51 g, 27%).
Data of 3,6-Bis{(1Z)-1-bromo-2-[4-(dodecyloxy)phenyl]ethenyl}pyridazine (3): Yellow crystals
which melt after recrystallization from hexane at 868 to the smectic phase SC. 1H-NMR (CDCl3): 0.89 (t,
2 Me); 1.22 (m, 32 H, CH2); 1.45 (m, 4 H, CH2); 1.78 (m, 4 H, CH2); 4.01 (t, 2 CH2O); 6.95, 7.89 (AA’BB’,
8 arom. H); 8.00 (s, 2 heteroarom. H); 8.55 (s, 2 olef. H). 13C-NMR (CDCl3): 14.1 (Me); 22.7, 26.0, 29.2,
29.3, 29.4, 29.6, 31.9 (CH2, partly superimposed); 68.2 (CH2O); 114.4, 126.0, 131.8, 133.6 (arom. and olef.
CH); 115.7 (olef. C); 127.4, 157.3, 160.0 (arom. C). FD-MS: 810 (100, Mþ (Br2 isotope pattern)). Anal.
calc. for C44H62Br2N2O2 (810.8): C 65.18, H 7.71, N 3.46; found: C 65.23, H 7.78, N 3.61.
Data of 3-{(1Z)-1-Bromo-2-[4-(dodecyloxy)phenyl]ethenyl}-6-{(1Z)-2-[4-(dodecyloxy)phenyl]-
ethenyl}pyridazine (4): Yellow crystals which melt after recrystallization from hexane at 918 to the
1
smectic phase SC. H-NMR (CDCl3): 0.89 (t, 2 Me); 1.23 (m, 32 H, CH2); 1.45 (m, 4 H, CH2); 1.78 (m,
4 H, CH2); 4.01 (m, 2 CH2O); 6.92, 7.54 (AA’BB’, 4 arom. H (nonbrominated side); 6.94, 7.86 (AA’BB’,
4 arom. H (brominated side); 7.22, 7.67 (AB, 3J ¼ 16.3, 2 olef. H); 7.58, 7.92 (AB, 3J ¼ 8.4, 2 heteroarom.
H); 8.47 (s, 1 olef. H); assignments based on INDOR and NOE. 13C-NMR (CDCl3): 14.0 (Me); 22.6, 26.0,
29.2, 29.3, 29.5, 29.6, 31.9 (CH2, partly superimposed); 68.1, 68.2 (CH2O); 114.3, 114.9, 122.2, 123.9, 125.6,
128.8, 131.6, 133.0, 134.9 (arom., heteroarom., and olef. CH); 116.2 (CBr); 127.7, 128.7, 156.9, 157.0, 159.9,
160.2 (arom. C). FD-MS: 730 (100, Mþ (Br isotope pattern)). Anal calc. for C44H63BrN2O2 (731.9): C
72.21, H 8.68, N 3.83; found: 72.04, H 8.48, N 3.94.
Data of 3-{(1Z)-1-Bromo-2-[3-bromo-4-(dodecyloxy)phenyl]ethenyl}-6-{(1Z)-1-bromo-2-[4-(dode-
1
cyloxy)phenyl]ethenyl}pyridazine (5): Yellow powder. M.p. 938. H-NMR (CDCl3): 0.86 (t, 2 Me); 1.27
(m, 32 H, CH2); 1.45 (m, 4 H, CH2); 1.79 (m, 4 H, CH2); 3.99 (t, 1 CH2O); 4.06 (t, 1 CH2O); 6.92, 7.76,
8.18 (ABC, 3 arom. H); 6.94, 7.88 (AA’BB’, 4 arom. H); 7.99, 8.01 (narrow AB, 2 heteroarom. H); 8.48 (s,
1 olef. H, 1 H); 8.56 (s, 1 olef. H). 13C-NMR (CDCl3): 14.1 (Me); 22.7, 26.0, 29.0, 29.2, 29.3, 29.6, 29.9
(CH2, partly superimposed); 68.2, 69.3 (CH2O); 112.1, 115.2, 116.9 (CBr); 112.4, 114.4, 126.0, 126.1,
130.8, 131.8, 132.3, 133.9, 134.6 (arom., heteroarom., and olef. CH); 127.5, 128.8, 156.1, 157.0, 157.6, 160.1
(arom. and heteroarom. C). Due to the very low yield of this by-product, we refrained from further
characterizations.
3. Chlorination of 1a to 3,6-Bis{(1Z)-1-chloro-2-[4-(dodecyloxy)phenyl]ethenyl}pyridazine (6).
Pyridazine 1a (5.0 g, 7.66 mmol) was suspended at 778 in dry CCl4 (100 ml). A soln. of SO2Cl2 (1.0 g,
7.41 mmol) in dry CCl4 (50 ml) was added dropwise. Several small portions of dibenzoyl peroxide were
added to the boiling mixture. The originally yellow color turned orange, and the suspended particles
dissolved. When the generation of SO2 ceased, the mixture was cooled to r.t. and washed with aq. Na2CO3
soln. and H2O. Evaporation of the solvent gave an orange residue. TLC (SiO2, CH2Cl2): three products
with Rf 0.3, 0.5, and 0.65, the latter corresponding to 6 as major product. Recrystallization of the orange
residue from CH2Cl2 and then from hexane yielded yellow needles of 6 (1.40 g, 25% rel. to 1a), which
melted at 1298 to the smectic SC phase. An equimolar or excess amount of SO2Cl2 cannot be
recommended to get highly pure 6 (Z,Z). 1H-NMR (CDCl3): 0.86 (t, 2 Me); 1.26 (m, 32 H, CH2); 1.43 (m,
4 H, CH2); 1.78 (m, 4 H, CH2); 3.99 (t, 2 CH2O); 6.94, 7.87 (AA’BB’, 8 arom. H); 7.96 (s, 2 heteroarom.
H). 13C-NMR (CDCl3): 14.1 (Me); 22.7, 26.1, 29.3, 29.4, 29.6, 29.7, 31.9 (CH2, partly superimposed); 68.2
(CH2O); 114.6, 124.0, 124.1, 126.9, 129.7, 132.1, 156.3, 160.0 (arom., heteroarom., and olef. C). FD-MS:
720 (100, Mþ (Cl2 isotope pattern)). Anal. calc. for C44H62Cl2N2O2 (721.9): C 73.21, H 8.66, N 3.88; found:
C 73.09, H 8.52, N 3.96.
4. Hydrogenation of 1a to 3,6-Bis{2-[4-(dodecyloxy)phenyl]ethyl}pyridazine (7). A suspension of 1a
(200 mg, 0.3 mmol) and 10% Pd/C (22 mg)) in dry DMF (70 ml) was stirred at 1108 under a pressure of
3.0 bar (3 · 105 Pa) H2 for 18 h. H2O (600 ml) was added, and the mixture was extracted with CH2Cl2 (3 ꢃ
50 ml). Concentration of the dried (MgSO4) org. phase gave a residue, which was twice recrystallized
from hexane. Colorless needles of 7 (120 mg, 60%) were obtained which melted at 888 to the smectic
1
phase. H-NMR (CDCl3): 0.86 (t, 2 Me); 1.24 (m, 32 H, CH2); 1.42 (m, 4 H, CH2); 1.74 (m, 4 H, CH2);
3.02, 3.19 (AA’BB’, 8 H, CH2CH2 (linker)); 3.90 (t, 2 CH2O); 6.78, 7.05 (AA’BB’, 8 arom. H); 6.97 (s, 2
heteroarom. H). 13C-NMR (CDCl3): 14.1 (Me); 22.7, 26.1, 29.3, 29.4, 29.4, 29.6, 29.6, 29.6, 29.7, 31.9
(CH2); 68.1 (CH2O); 34.7, 38.0 (CH2 (linker)); 114.6, 126.3, 129.4 (arom. and heteroarom. CH); 132.8,